Is PT-141 Safe?

Is PT-141 Safe?

Overview

PT-141 is a compounded injectable prescribed by a licensed provider. A medical assessment is required before PT-141 is prescribed.

Who Should Not Use PT-141

  • Patients who are pregnant or breastfeeding.
  • Patients who have a history of cancer or active cancer.
  • Children and adolescents.

Medical Assessment

A medical assessment is required before PT-141 is prescribed. Your provider will review your health history, current medications, and indication to confirm PT-141 is appropriate for you.

Contact your care team through the patient portal or at 888-696-7176.


    • Related Articles

    • What's Included in the PT-141 Package?

      What You'll Receive Your PT-141 shipment includes: PT-141 peptide vial Needles Alcohol swabs Pamphlet Do I Need to Buy Anything Separately? No. Everything needed to administer your PT-141 protocol is included. You will also need a sharps container ...

    • What Is PT-141 & How Does It Work?

      About PT-141 PT-141 (Bremelanotide Acetate) targets the central nervous system to facilitate a natural increase in sexual desire and arousal signals at the source. PT-141 is a compounded peptide prescribed by a licensed provider. It works through the ...

    • Is injectable Semaglutide safe?

      Semaglutide injections (for example, the FDA-approved medications Wegovy® and Ozempic®) have been studied in clinical trials and, when used under the supervision of a licensed healthcare provider, can have a favorable benefit-risk profile for ...

    • Are DHEA Capsules safe?

      DHEA is a hormone your body already produces naturally, and supplementing it at the right dose is considered safe under medical supervision. Because it converts to small amounts of estrogen and testosterone in the body, getting the dose right matters ...

    • Is Revionyx (Epithalon) safe?

      Epithalon has been studied for several decades and demonstrates a strong safety profile in both animal and limited human research. To date, no serious adverse events have been reported in clinical literature. However, as with any injectable peptide, ...